日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions

携带NTRK基因融合的中枢神经系统肿瘤的临床特征和预后

Lamoureux, Audrey-Anne; Fisher, Michael J; Lemelle, Lauriane; Pfaff, Elke; Amir-Yazdani, Pouneh; Kramm, Christof; De Wilde, Bram; Kazanowska, Bernarda; Hutter, Caroline; Pfister, Stefan M; Sturm, Dominik; Jones, David T W; Orbach, Daniel; Pierron, Gaëlle; Raskin, Scott; Drilon, Alexander; Diamond, Eli L; Harada, Guilherme; Zapotocky, Michal; Zamecnik, Josef; Krskova, Lenka; Ellezam, Benjamin; Weil, Alexander G; Venne, Dominic; Barritault, Marc; Leblond, Pierre; Coltin, Hallie; Hammad, Rawan; Tabori, Uri; Hawkins, Cynthia; Hansford, Jordan R; Meyran, Deborah; Erker, Craig; McFadden, Kathryn; Sato, Mariko; Gottardo, Nicholas G; Dholaria, Hetal; Nørøxe, Dorte Schou; Goto, Hiroaki; Ziegler, David S; Lin, Frank Y; Parsons, Donald Williams; Lindsay, Holly; Wong, Tai-Tong; Liu, Yen-Lin; Wu, Kuo-Sheng; Franson, Andrea T; Hwang, Eugene; Aguilar-Bonilla, Ana; Cheng, Sylvia; Cacciotti, Chantel; Massimino, Maura; Schiavello, Elisabetta; Wood, Paul; Hoffman, Lindsey M; Cappellano, Andréa; Lassaletta, Alvaro; Van Damme, An; Llort, Anna; Gerber, Nicolas U; Spalato Ceruso, Mariella; Bendel, Anne E; Skrypek, Maggie; Hamideh, Dima; Mushtaq, Naureen; Walter, Andrew; Jabado, Nada; Alsahlawi, Aysha; Farmer, Jean-Pierre; Coleman, Christina; Mueller, Sabine; Mazewski, Claire; Aguilera, Dolly; Robison, Nathan J; O'Halloran, Katrina; Abbou, Samuel; Berlanga, Pablo; Geoerger, Birgit; Øra, Ingrid; Moertel, Christopher L; Razis, Evangelia D; Vernadou, Anastasia; Ducray, François; Bronnimann, Charlotte; Seizeur, Romuald; Clarke, Matthew; Resnick, Adam C; Alves, Mélanie; Jones, Chris; Doz, François; Laetsch, Theodore W; Perreault, Sébastien

Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors

接受免疫检查点抑制剂治疗的晚期实体瘤患者出现类似结节病的反应

Nykaza, Ian; Murciano-Goroff, Yonina R; Desilets, Antoine; Harada, Guilherme; Postow, Michael A; Callahan, Margaret K; Lee, Chung-Han; Rudin, Charles M; Kelsen, David Paul; Stadler, Zsofia K; Wibmer, Andreas G; Hechtman, Jaclyn F; Drilon, Alexander; Friedman, Claire F

Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292)

使用高选择性RET激酶抑制剂Selpercatinib(LOXO-292)治疗癌症患者的黏膜皮肤不良事件

Reingold, Rachel E; Parisi, Rose; Harada, Guilherme; Moy, Andrea P; Dranitsaris, George; Francis, Jasmine H; Canestraro, Julia; Lester, Julia A; Kaplanis, Lauren A; Liu, Dazhi; Lacouture, Mario E; Drilon, Alexander

A Phase II Study of Cabozantinib in Patients With MET-Altered Lung Cancers

卡博替尼治疗MET基因改变肺癌患者的II期研究

Harada, Guilherme; Santini, Fernando C; Wilhelm, Clare J; Repetti, Rebecca W; Chang, Jason C; Yang, Soo-Ryum; Lin, Yun-Te; Moses, Khadeja A; Falcon, Christina; Goldstein, Michelle; Makhnin, Alex; Ginsberg, Michelle S; Plodkowski, Andrew J; Kris, Mark G; Drilon, Alexander

Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to "False" Decreases in Renal Function

简报:用于治疗肺癌的酪氨酸激酶抑制剂(可抑制MATE-1)可能导致肾功能“假性”下降

Chen, Monica F; Harada, Guilherme; Liu, Dazhi; DeMatteo, Ray; Falcon, Christina; Wilhelm, Clare; Kris, Mark G; Drilon, Alexander; Gutgarts, Victoria

Author Correction: TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers

作者更正:TKI类型转换可克服ROS1融合阳性癌症中的ROS1 L2086F突变

Thawani, Rajat; Repetto, Matteo; Keddy, Clare; Nicholson, Katelyn; Jones, Kristen; Nusser, Kevin; Beach, Catherine Z; Harada, Guilherme; Drilon, Alexander; Davare, Monika A

TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers.

TKI 类型转换可克服 ROS1 融合阳性癌症中的 ROS1 L2086F 突变

Thawani Rajat, Repetto Matteo, Keddy Clare, Nicholson Katelyn, Jones Kristen, Nusser Kevin, Beach Catherine Z, Harada Guilherme, Drilon Alexander, Davare Monika A

Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents

Zurletrectinib 是一种新一代 TRK 抑制剂,对具有靶向耐药性的 NTRK 融合阳性肿瘤具有强大的颅内活性。

Roa, Paola; Foglizzo, Valentina; Harada, Guilherme; Repetto, Matteo; Kulick, Amanda; de Stanchina, Elisa; de Marchena, Michelle; Auwardt, Supipi; Sayed Ahmed, Shaza; Bremer, Nicole Virginia; Yang, Soo-Ryum; Feng, Yangbo; Zhou, Chao; Kong, Norman; Liang, Ruixia; Xu, Haipeng; Zhang, Bin; Bardelli, Alberto; Toska, Eneda; Ventura, Andrea; Drilon, Alexander; Cocco, Emiliano

Basket Trials: Past, Present, and Future

篮子试验:过去、现在和未来

Murciano-Goroff, Yonina R; Uppal, Manik; Chen, Monica; Harada, Guilherme; Schram, Alison M

Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC

肿瘤内在分子特征对ALK阳性非小细胞肺癌患者生存和获得性酪氨酸激酶抑制剂耐药性的影响

Nakazawa, Mari; Harada, Guilherme; Ghanem, Paola; Bubie, Adrian; Kiedrowski, Lesli A; Murray, Joseph C; Marrone, Kristen A; Scott, Susan C; Houseknecht, Stefanie; Falcon, Christina J; Evans, Patrick; Feliciano, Josephine; Hann, Christine L; Ettinger, David S; Smith, Kellie N; Anagnostou, Valsamo; Forde, Patrick M; Brahmer, Julie R; Levy, Benjamin; Drilon, Alexander; Lam, Vincent K